Tiegatonium bromide freeze-dried preparation as well as preparation method and application thereof
By combining tialigy bromide with pH regulator and stent agent and freeze-drying, the stability of lyophilized tialigy bromide preparation is solved, and a stable atomized inhalation preparation is achieved, which improves the efficacy and safety of the drug sex.
Patent Information
- Application Number
- CN202411050348.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-11-19
AI Technical Summary
Existing M3 type cholinergic receptor antagonists have defects in their efficacy or safety, especially because tiegium bromide is prone to hydrolysis of ester bonds in the chemical structure, resulting in the unstable lyophilized preparation under accelerated and long-term conditions. It is difficult to develop stable atomization inhalation preparations.
Using a preparation method of lyophilized tialuminum bromide preparation, the stent agent (such as lactose, sodium chloride, sodium chloride, citric acid) and stent agent (such as lactose, sodium chloride ) The lyophilized tiacin bromide preparation is good for stability by controlling the pH of the drug solution to 2-5 and freeze-dried.
The stability of the lyophilized tiacin bromide preparation has been improved, which has increased the long-term storage and service life of the drug, reduced the generation of impurities, and met the needs of clinical atomized drug delivery.
Smart Images

Figure CN118975991A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of medicines, and in particular relates to a thiocarbamide lyophilized preparation and a preparation method and application thereof. Background Art
[0002] Chronic obstructive pulmonary disease (COPD) is a common and multiple progressive respiratory disease, including chronic bronchitis, bronchiectasis, asthma, cystic fibrosis, etc., with high morbidity and mortality. Anticholinergic drugs are COPD treatment drugs with rapid development in recent years. Muscarinic acetylcholine receptors (mAChR) are important neurotransmitter receptors widely distributed in the central nervous system and peripheral parasympathetic nerves, and can be divided into five receptor subtypes, M1-M5. Ideal COPD anticholinergic drugs should antagonize M1 and M3 receptors and have less affinity for M2 receptors.
[0003] At present, the main long-acting M3 receptor antagonists used as important bronchodilators for the treatment of COPD are tiotropium bromide (TB), aclidinium bromide (AB) and glycopyrronium bromide (GB). However, the above drugs have no selectivity for M1, M2 and M3 receptors. In addition, AB has extremely poor plasma stability and requires a very high dosage; while TB and GB have very high plasma stability, which can cause adverse reactions such as dry mouth and constipation, and also cause severe cardiac toxicity. Existing M3 muscarinic receptor antagonists still have defects to varying degrees in terms of efficacy or safety. Therefore, the development of M3 receptor antagonists with suitable plasma stability and good selectivity is very valuable for the clinical treatment of COPD.
[0004] Thiogrenate bromide is a highly selective M3 cholinergic receptor inhibitor discovered in recent years. Its molecule contains the advantageous structural fragments of quaternary ammonium bromide COPD therapeutic drugs, while overcoming its potential pharmacokinetic defects. It is a potential candidate drug for the treatment of COPD. It is of great significance to develop it into a suitable preparation for the treatment of COPD. Inhaled liquid preparations, due to their local administration, improve the accumulation of drugs in target organs, increase efficacy while reducing toxic side effects, and are commonly used dosage forms for the treatment of lung and respiratory diseases.
[0005] However, at present, there are no relevant reports on the inhalation liquid preparation of thiocarbamide bromide. The challenge of developing a thiocarbamide bromide liquid preparation for atomization inhalation is that there is an ester bond in the chemical structure of thiocarbamide bromide, which is easily hydrolyzed. Ester bond hydrolysis is usually closely related to pH, and in the bromide inhalation solution products that have been listed, buffer pairs (such as acetic acid-sodium acetate, citric acid-sodium citrate, etc.) are often used to regulate pH, and buffer pairs as pH regulators are more conducive to maintaining the pH stability of the liquid. However, after research, it was found that according to the research and development ideas of bromide that have been listed, adding an acid-base buffer pair as a pH regulator to the thiocarbamide lyophilized prescription does not make the lyophilized product stable under accelerated and long-term conditions. Therefore, how to maintain the stability of the active ingredient during the preparation, storage, and use of the lyophilized preparation has become a challenge in the process of preparing a stable thiocarbamide lyophilized preparation. Summary of the invention
[0006] The technical problem solved by the present invention is to provide a stable thiocarbamide lyophilized preparation, and the obtained thiocarbamide lyophilized powder for atomization inhalation has good stability. The first technical problem to be solved by the present invention is to provide a preparation method of a stable thiocarbamide lyophilized preparation, and the preparation method has the characteristics of simple process, green safety and environmental protection. Another technical problem to be solved by the present invention is to provide the application of the above-mentioned thiocarbamide lyophilized preparation in the preparation of drugs for treating COPD.
[0007] In order to solve the above technical problems, the technical solution adopted by the present invention is as follows:
[0008] A thiocarbamide freeze-dried preparation is prepared by freeze-drying a thiocarbamide liquid, wherein the thiocarbamide liquid consists of an active component and auxiliary materials; the active component is thiocarbamide, and the auxiliary materials include a pH regulator, a scaffolding agent and water.
[0009] Preferably, in the thiocarbamide solution, the concentration of thiocarbamide is 0.01 to 0.4 mg / mL.
[0010] Preferably, the pH regulator is selected from one or more of hydrochloric acid, acetic acid, sodium bisulfate and citric acid.
[0011] Preferably, the pH adjuster adjusts the pH of the thiocarbamide solution to 2-5.
[0012] Preferably, the scaffold agent is selected from one or both of lactose and sodium chloride.
[0013] Preferably, the concentration of the scaffold agent is 3 to 100 mg / mL.
[0014] A method for preparing the thiocarbamide lyophilized preparation, comprising a liquid preparation process and a freeze-drying process;
[0015] The liquid preparation process includes:
[0016] (1) dissolving a pH regulator and a scaffolding agent in water to control the pH to be between 2 and 5;
[0017] (2) adding thiophene bromide and stirring until dissolved, fixing the volume and filtering to obtain thiophene bromide solution;
[0018] The freeze-drying process comprises: (3) packaging the obtained thiocarbamide liquid into freeze-drying bottles, and performing freeze-drying to obtain a thiocarbamide freeze-dried preparation.
[0019] 8. The method for preparing a lyophilized preparation of thiocarbamide bromide according to claim 7, characterized in that the freeze-drying process specifically comprises:
[0020] S1. Pre-freezing stage:
[0021] First, set the plate temperature to 0~-10℃, set the cooling rate to 0.2~0.8℃ / min, and keep it for 10~60min; then set the plate temperature to -45~-30℃, set the cooling rate to 0.2~0.8℃ / min, and keep it for 2~8h;
[0022] S2. Primary drying stage:
[0023] Set the plate temperature to -30~-10℃, set the heating rate to 0.2~0.8℃ / min, hold time to 10~20h, and vacuum degree to 0.05~0.25mBar;
[0024] S3. Secondary drying stage:
[0025] Set the plate temperature to 30-50°C, the heating rate to 0.2-0.8°C / min, the holding time to 2-10h, and the vacuum degree to 0.05-0.25mBar.
[0026] Preferably, the freeze drying is performed until the water content in the thiocarbamide lyophilized preparation is no more than 5%.
[0027] The application of the thiocarbamide lyophilized preparation in the preparation of drugs for treating COPD.
[0028] Beneficial effects: Compared with the prior art, the present invention has the following advantages:
[0029] (1) The present invention provides a method for preparing a stable thiocarbamide lyophilized powder for aerosol inhalation. Thiocarbamide is a highly selective M3 cholinergic receptor inhibitor, but it is chemically unstable. The thiocarbamide lyophilized powder for aerosol inhalation prepared by the present invention has good stability, low impurity content after accelerated 6 months, and can be stored for a long time at room temperature;
[0030] (2) The thiocarbamide bromide solution of the present invention (before freeze-drying) has a low increase in impurities within 24 hours, good long-term stability, and lyophilization production is feasible; after reconstitution, the increase in stable impurities within 6 hours is low, the stability is good, and the time requirement of clinical aerosol drug administration is met;
[0031] (3) The freeze-dried preparation preparation method provided by the present invention can reduce the degradation of thiocarbamide, reduce the increase in impurities during the preparation, storage and administration process, and improve the stability of the thiocarbamide freeze-dried preparation. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] Figure 1 The following are photos of the freeze-dried preparations prepared in Examples 1-13. DETAILED DESCRIPTION
[0033] The present invention will be further illustrated below in conjunction with specific examples. The examples are implemented under the premise of the technical solution of the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. If specific conditions are not specified in the examples, they are carried out according to normal conditions or the conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be purchased commercially.
[0034] Example 1
[0035] 1. Prescription (pH adjuster: citric acid; pH of the drug solution: 3.5; concentration of the main drug: 0.2 mg / mL; scaffold agent: lactose)
[0036] Table 1 Thioglobin bromide solution formula
[0037]
[0038] 2. Preparation method
[0039] Take 90% of the prescribed amount of water for injection, add citric acid to adjust the pH to 3.5, add lactose, stir until dissolved, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 1 mL / vial, freeze-dried according to the freeze-drying procedure in Table 2, plugged, unpacked, and covered with an aluminum-plastic composite cover.
[0040] Table 2 Freeze-drying procedure
[0041]
[0042] Example 2
[0043] 1. Prescription (pH adjuster: citric acid; drug solution: pH 3.5; main drug concentration: 0.2 mg / mL; scaffold agent: lactose)
[0044] Table 3 Thioglobin bromide solution formula
[0045]
[0046] 2. Preparation method
[0047] Prepare 0.1M citric acid solution, take 80% of the prescribed amount of water for injection, add lactose, stir until dissolved, add 0.1M citric acid to adjust the pH to 3.5, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 1mL / vial, freeze-dried according to the freeze-drying procedure in Table 4 below, plugged, unpacked, and covered with an aluminum-plastic composite cover.
[0048] Table 4 Freeze-drying procedure
[0049]
[0050] Example 3
[0051] 1. Prescription (pH adjuster: hydrochloric acid; pH of the drug solution: 3.5; concentration of the main drug: 0.2 mg / mL; scaffold agent: lactose)
[0052] Table 5 Thiocyanate bromide solution formula
[0053]
[0054] 2. Preparation method
[0055] Take 90% of the prescribed amount of water for injection, add hydrochloric acid to adjust the pH to 3.5, add lactose, stir until dissolved, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 1 mL / vial, freeze-dried according to the freeze-drying procedure in Table 6 below, plugged, unpacked, and covered with an aluminum-plastic composite cover to obtain.
[0056] Table 6 Freeze-drying procedure
[0057]
[0058]
[0059] Example 4
[0060] 1. Prescription (pH adjuster: acetic acid; pH of the drug solution: 3.5; concentration of the main drug: 0.2 mg / mL; scaffold agent: lactose)
[0061] Table 7 Thioglobin Bromide Solution Formula
[0062]
[0063] 2. Preparation method
[0064] Take 90% of the prescribed amount of water for injection, add acetic acid to adjust the pH to 3.5, add lactose, stir until dissolved, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 1 mL / vial, freeze-dried according to the freeze-drying procedure in Table 8 below, plugged, unpacked, and covered with an aluminum-plastic composite cover to obtain.
[0065] Table 8 Freeze-drying procedure
[0066]
[0067] Example 5
[0068] 1. Prescription (pH adjuster: sodium bisulfate; pH of the drug solution: 3.5; concentration of the main drug: 0.2 mg / mL; scaffold agent: lactose)
[0069] Table 9 Thiocyanate Bromide Solution Formula
[0070]
[0071] 2. Preparation method
[0072] Take 90% of the prescribed amount of water for injection, add sodium bisulfate to adjust the pH to 3.5, add lactose, stir until dissolved, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 1 mL / vial, freeze-dried according to the freeze-drying procedure in Table 10 below, plugged, unpacked, and covered with an aluminum-plastic composite cover to obtain.
[0073] Table 10 Freeze-drying procedure
[0074]
[0075] Example 6
[0076] 1. Prescription (pH adjuster: citric acid; pH of the drug solution: 3.5; concentration of the main drug: 0.02 mg / mL; scaffold agent: lactose)
[0077] Table 11 Thiocyanate Bromide Solution Formula
[0078]
[0079] 2. Preparation method
[0080] Take 90% of the prescribed amount of water for injection, add citric acid to adjust the pH to 3.5, add lactose, stir until dissolved, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 1 mL / vial, freeze-dried according to the freeze-drying procedure in Table 12 below, plugged, unpacked, and covered with an aluminum-plastic composite cover to obtain.
[0081] Table 12 Freeze-drying procedure
[0082]
[0083]
[0084] Example 7
[0085] 1. Prescription (pH adjuster: citric acid; pH of the drug solution: 3.0; concentration of the main drug: 0.1 mg / mL; scaffold agent: sodium chloride)
[0086] Table 13 Thiocyanate bromide solution formula
[0087]
[0088] 2. Preparation method
[0089] Prepare 0.01M citric acid solution, take 65% of the prescription amount of water for injection, add sodium chloride, stir until solvent, add 0.01M citric acid solution to adjust the pH to 3.0, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 2mL / vial, freeze-dried according to the freeze-drying procedure in Table 14 below, plugged, unpacked, and covered with an aluminum-plastic composite cover.
[0090] Table 14 Lyophilization procedure
[0091]
[0092] Example 8
[0093] 1. Prescription (pH adjuster: citric acid; pH of the drug solution: 3.0; concentration of the main drug: 0.1 mg / mL; scaffold agent: lactose)
[0094] Table 15 Thiocyanate bromide solution formula
[0095]
[0096]
[0097] 2. Preparation method
[0098] Prepare 0.01M citric acid solution, take 65% of the prescription amount of water for injection, add lactose, stir until dissolved, add 0.01M citric acid solution to adjust the pH to 3.0, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 2mL / vial, freeze-dried according to the freeze-drying procedure in Table 16 below, plugged, unpacked, and covered with an aluminum-plastic composite cover.
[0099] Table 16 Freeze-drying procedure
[0100]
[0101] Example 9
[0102] 1. Prescription (pH adjuster: citric acid; pH of the drug solution: 3.0; concentration of the main drug: 0.1 mg / mL; scaffold agent: sodium chloride-lactose)
[0103] Table 17 Thioglobin Bromide Solution Formula
[0104]
[0105] 2. Preparation method
[0106] Prepare 0.01M citric acid solution, take 65% of the prescription amount of water for injection, add sodium chloride and lactose, stir until dissolved, add 0.01M citric acid solution to adjust the pH to 3.0, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 2mL / vial, freeze-dried according to the freeze-drying procedure in Table 18 below, plugged, unpacked, and covered with an aluminum-plastic composite cover.
[0107] Table 18 Lyophilization procedure
[0108]
[0109] Example 10
[0110] 1. Prescription (pH adjuster: citric acid; pH of the drug solution: 3.0; concentration of the main drug: 0.1 mg / mL; scaffold agent: sodium chloride-lactose)
[0111] Table 19 Thiocyanate bromide solution formula
[0112]
[0113] 2. Preparation method
[0114] Prepare 0.01M citric acid solution, take 65% of the prescription amount of water for injection, add sodium chloride and lactose, stir until dissolved, add 0.01M citric acid solution to adjust the pH to 3.0, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 2mL / tube, freeze-dried according to the freeze-drying procedure in Table 20 below, plugged, unpacked, and covered with an aluminum-plastic composite cover.
[0115] Table 20 Freeze-drying procedure
[0116]
[0117]
[0118] Embodiment 11
[0119] 1. Prescription (pH adjuster: citric acid; pH of the drug solution: 3.0; concentration of the main drug 0.1: mg / mL; scaffold agent: sodium chloride-lactose)
[0120] Table 21 Thiocyanate bromide solution formula
[0121]
[0122] 2. Preparation method
[0123] Prepare 0.01M citric acid solution, take 65% of the prescription amount of water for injection, add sodium chloride and lactose, stir until dissolved, add 0.01M citric acid solution to adjust the pH to 3.0, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 2mL / vial, freeze-dried according to the freeze-drying procedure in Table 22 below, plugged, unpacked, and covered with an aluminum-plastic composite cover.
[0124] Table 22 Freeze drying procedure
[0125]
[0126] Example 12
[0127] 1. Prescription (pH adjuster: citric acid; pH of the drug solution: 4.0; concentration of the main drug: 0.1 mg / mL; scaffold agent: sodium chloride-lactose)
[0128] Table 23 Thioglobin bromide solution formula
[0129]
[0130] 2. Preparation method
[0131] Prepare 0.01M citric acid solution, take 65% of the prescription amount of water for injection, add sodium chloride and lactose, stir until dissolved, add 0.01M citric acid solution to adjust the pH to 4.0, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 2mL / vial, freeze-dried according to the freeze-drying procedure in Table 24 below, plugged, unpacked, and covered with an aluminum-plastic composite cover.
[0132] Table 24 Lyophilization procedure
[0133]
[0134] Embodiment 13
[0135] 1. Prescription (pH adjuster: citric acid; pH of the drug solution: 4.0; concentration of the main drug: 0.1 mg / mL; scaffold agent: sodium chloride-lactose)
[0136] Table 25 Thiocyanate bromide solution formula
[0137]
[0138]
[0139] 2. Preparation method
[0140] Prepare 0.01M citric acid solution, take 65% of the prescription amount of water for injection, add sodium chloride and lactose, stir until dissolved, add 0.01M citric acid solution to adjust the pH to 4.0, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 2mL / vial, freeze-dried according to the freeze-drying procedure in Table 26 below, plugged, unpacked, and covered with an aluminum-plastic composite cover.
[0141] Table 26 Lyophilization procedure
[0142]
[0143] Comparative Example 1
[0144] 1. Prescription (pH adjuster: citric acid-sodium citrate; pH of the drug solution: 3.0; concentration of the main drug: 0.2 mg / mL; scaffold agent: lactose)
[0145] Table 27 Thioglobin Bromide Solution Formula
[0146]
[0147] 2. Preparation method
[0148] Prepare 0.01M citric acid and 0.01M sodium citrate solution, use 0.01M citric acid and 0.01M sodium citrate to prepare about 900ml of pH 3.0 solution, add lactose, stir until dissolved, add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles according to 1mL / piece, freeze-dried according to the freeze-drying procedure of Table 28 below, plugged, unpacked, and covered with an aluminum-plastic composite cover.
[0149] Table 28 Lyophilization procedure
[0150]
[0151] Comparative Example 2
[0152] 1. Prescription (pH adjuster: citric acid-sodium citrate; pH of the drug solution: 3.5; concentration of the main drug: 0.2 mg / mL; scaffold agent: lactose)
[0153] Table 29 Thiocyanate bromide solution formula
[0154]
[0155] 2. Preparation method
[0156] Take 90% of the prescribed amount of water for injection, add citric acid and sodium citrate to adjust the pH to 3.5, add lactose to dissolve in the solution, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 1 mL / vial, freeze-dried according to the freeze-drying procedure in Table 30 below, plugged, unpacked, and covered with an aluminum-plastic composite cover.
[0157] Table 30 Freeze-drying procedure
[0158]
[0159] Comparative Example 3
[0160] 1. Prescription (pH adjuster: citric acid-sodium citrate; pH of the drug solution: 4.0; concentration of the main drug: 0.2 mg / mL; scaffold agent: lactose)
[0161] Table 31 Thioglobin Bromide Solution Formula
[0162]
[0163] 2. Preparation method
[0164] Use 0.01M citric acid and 0.01M sodium citrate to prepare about 900ml of pH 4.0 solution, add lactose to dissolve in the solution, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 1mL / vial, freeze-dried according to the freeze-drying procedure in Table 32 below, plugged, unpacked, and covered with an aluminum-plastic composite cover to obtain.
[0165] Table 32 Freeze-drying procedure
[0166]
[0167] Comparative Example 4
[0168] 1. Prescription (pH adjuster: citric acid and lysine; main drug concentration: 0.2 mg / mL; scaffold agent: lysine)
[0169] Table 33 Thioglobin bromide solution formula
[0170]
[0171] 2. Preparation method
[0172] Take 900 ml of water for injection, add citric acid, dissolve, add lysine to dissolve in the solution, add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, measure the pH to be 10.0, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-drying bottles at 2 mL / piece, and freeze-dried according to the freeze-drying program in Table 34 below.
[0173] Table 34 Freeze-drying procedure
[0174]
[0175] Comparative Example 5
[0176] 1. Prescription (pH adjuster: none; main drug concentration: 0.2 mg / mL; scaffold agent: lactose)
[0177] Table 35 Thiocyanate bromide solution formula
[0178]
[0179] 2. Preparation method
[0180] Take 90% of the prescribed amount of water for injection, add lactose, stir until dissolved, measure the pH, then add thiocarbamide bromide and stir until dissolved, add water for injection to the full amount, filter, and obtain the thiocarbamide bromide liquid composition. The liquid composition is divided into freeze-dried bottles at 1 mL / vial, freeze-dried according to the freeze-drying procedure in Table 36, plugged, unpacked, and covered with an aluminum-plastic composite cover to obtain.
[0181] Table 36 Lyophilization procedure
[0182]
[0183] Embodiment 14
[0184] The appearance, content, related substances, water content, reconstitution time of thiocarbamide bromide lyophilized powder with normal saline, pH after reconstitution,
[0185] Table 37 Results of freeze-dried powder content, related substances, moisture, reconstitution time, and pH after reconstitution of Examples 1-13 and Comparative Examples 4-5
[0186]
[0187]
[0188] Depend on Figure 1 As can be seen from Table 37, the appearance, rapid reconstitution, moisture content, and related substances of the freeze-dried products prepared in Examples 1-13 are ideal, while the sample of Comparative Example 4 collapses after freeze-drying, and the main component is basically completely degraded.
[0189] Embodiment 15
[0190] Stability test of drug solution before lyophilization: The thiocarbamide bromide drug solution (before lyophilization) prepared in Examples 1, 3-6, 10-13 and Comparative Example 5 was placed at room temperature for 24 hours, and the related substances were determined. The results are shown in Table 38.
[0191] Table 38 Related substances of drug solution (before freeze-drying)
[0192]
[0193]
[0194] It can be seen from Table 38 that when no pH regulator is added to the solution of Comparative Example 5, the thiocarbamide solution is unstable. In each embodiment where an acidic regulator is added (pH is in the range of 3 to 4), the mass of related substances in the thiocarbamide solution is less than 2% within 24 hours.
[0195] Example 16
[0196] Stability test of the drug solution after reconstitution of the lyophilized powder: The thiocarbamide lyophilized powder prepared in Examples 1, 3-6, and 10-13 was reconstituted into a solution using physiological saline (sodium chloride solution for injection), and then placed at room temperature for a certain period of time. The related substances in the drug solution were determined. The results are shown in Table 39.
[0197] Table 39 Related substances in the reconstituted drug solution of freeze-dried products of different scaffold formulations
[0198]
[0199]
[0200] It can be seen from Table 39 that the lyophilized powders prepared in Examples 1, 3-6, and 10-13 can remain stable for at least 2 hours after reconstitution (related substances <2%), which can meet the needs of clinical medication.
[0201] Embodiment 17
[0202] Accelerated stability test of freeze-dried powder: The thiocarbamide freeze-dried powder prepared in Examples 1-6 and Comparative Examples 1-3 was subjected to accelerated conditions (40°C, RH75%) to examine the content of related substances. The results are shown in Table 40.
[0203] Table 40 Accelerated stability test results of thiocarbamide lyophilized powder prepared in Examples 1-6 and Comparative Examples 1-3
[0204]
[0205] As shown in Table 40, the stability results of the lyophilized products prepared in Example 1, Example 2 and Comparative Example 2 of the present invention under accelerated conditions show that even if the pH of the drug solution before lyophilization is the same, there is no significant difference in the stability of the drug solution, but there is a significant difference in the stability of the lyophilized powder under accelerated conditions. The stability of the lyophilized powder of Thiotropium bromide using only an acidic regulator under accelerated conditions is significantly improved (total impurities are significantly reduced). The lyophilized powder of Thiotropium bromide prepared in Examples 1, 2, 3, 4, 5, and 6 of the present invention all show good stability, especially in Examples 1, 2, 3, and 5, under accelerated conditions for 6 months, total impurities are still <2%.
[0206] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A lyophilized preparation of thiocarbamide bromide, characterized in that: The invention is prepared by freeze-drying a thiophene bromide liquid, wherein the thiophene bromide liquid consists of an active component and auxiliary materials; the active component is thiophene bromide, and the auxiliary materials include a pH regulator, a scaffolding agent and water.
2. The lyophilized preparation of thiocarbamide bromide according to claim 1, characterized in that In the thiocarbamide solution, the concentration of thiocarbamide is 0.01-0.4 mg / mL.
3. The lyophilized preparation of thiocarbamide bromide according to claim 1, characterized in that The pH regulator is selected from one or more of hydrochloric acid, acetic acid, sodium bisulfate, and citric acid.
4. The lyophilized preparation of thiocarbamide bromide according to claim 3, characterized in that The pH regulator adjusts the pH of the thiocarbamide solution to 2-5.
5. The lyophilized preparation of thiocarbamide bromide according to claim 1, characterized in that The scaffold agent is selected from one or both of lactose and sodium chloride.
6. The lyophilized preparation of thiocarbamide bromide according to claim 1, characterized in that The concentration of the scaffold agent is 3-100 mg / mL.
7. A method for preparing the lyophilized preparation of thiocarbamide bromide according to claim 1, characterized in that: Including liquid preparation process and freeze drying process; The liquid preparation process includes: (1) dissolving a pH regulator and a scaffolding agent in water to control the pH to be between 2 and 5; (2) adding thiophene bromide and stirring until dissolved, fixing the volume and filtering to obtain thiophene bromide solution; The freeze-drying process comprises: (3) packaging the obtained thiocarbamide liquid into freeze-drying bottles, and performing freeze-drying to obtain a thiocarbamide freeze-dried preparation.
8. The method for preparing a lyophilized preparation of thiocarbamide bromide according to claim 7, characterized in that: The freeze drying process specifically comprises: S1. Pre-freezing stage: First, set the plate temperature to 0~-10℃, set the cooling rate to 0.2~0.8℃ / min, and keep it for 10~60min; then set the plate temperature to -45~-30℃, set the cooling rate to 0.2~0.8℃ / min, and keep it for 2~8h; S2. Primary drying stage: Set the plate temperature to -30~-10℃, set the heating rate to 0.2~0.8℃ / min, hold time to 10~20h, and vacuum degree to 0.05~0.25mBar; S3. Secondary drying stage: Set the plate temperature to 30-50°C, the heating rate to 0.2-0.8°C / min, the holding time to 2-10h, and the vacuum degree to 0.05-0.25mBar.
9. The method for preparing a lyophilized preparation of thiocarbamide bromide according to claim 7, characterized in that: The freeze drying is performed until the water content in the thiocarbamide lyophilized preparation is no more than 5%.
10. Use of the lyophilized preparation of thiocarbamide bromide according to any one of claims 1 to 6 in the preparation of a drug for treating COPD.
